216 related articles for article (PubMed ID: 23563608)
1. SMIM1 underlies the Vel blood group and influences red blood cell traits.
Cvejic A; Haer-Wigman L; Stephens JC; Kostadima M; Smethurst PA; Frontini M; van den Akker E; Bertone P; Bielczyk-Maczyńska E; Farrow S; Fehrmann RS; Gray A; de Haas M; Haver VG; Jordan G; Karjalainen J; Kerstens HH; Kiddle G; Lloyd-Jones H; Needs M; Poole J; Soussan AA; Rendon A; Rieneck K; Sambrook JG; Schepers H; Silljé HHW; Sipos B; Swinkels D; Tamuri AU; Verweij N; Watkins NA; Westra HJ; Stemple D; Franke L; Soranzo N; Stunnenberg HG; Goldman N; van der Harst P; van der Schoot CE; Ouwehand WH; Albers CA
Nat Genet; 2013 May; 45(5):542-545. PubMed ID: 23563608
[TBL] [Abstract][Full Text] [Related]
2. Homozygosity for a null allele of SMIM1 defines the Vel-negative blood group phenotype.
Storry JR; Jöud M; Christophersen MK; Thuresson B; Åkerström B; Sojka BN; Nilsson B; Olsson ML
Nat Genet; 2013 May; 45(5):537-41. PubMed ID: 23563606
[TBL] [Abstract][Full Text] [Related]
3. Disruption of SMIM1 causes the Vel- blood type.
Ballif BA; Helias V; Peyrard T; Menanteau C; Saison C; Lucien N; Bourgouin S; Le Gall M; Cartron JP; Arnaud L
EMBO Mol Med; 2013 May; 5(5):751-61. PubMed ID: 23505126
[TBL] [Abstract][Full Text] [Related]
4. The c.64_80del SMIM1 allele is segregating in the Hutterite population.
Coghlan G; Zelinski T
Transfusion; 2016 Apr; 56(4):946-9. PubMed ID: 26666208
[TBL] [Abstract][Full Text] [Related]
5. SMIM1 missense mutations exert their effect on wild type Vel expression late in erythroid differentiation.
van der Rijst MVE; Abay A; Aglialoro F; van der Schoot CE; van den Akker E
Transfusion; 2021 Jan; 61(1):236-245. PubMed ID: 33128268
[TBL] [Abstract][Full Text] [Related]
6. SMIM1 polymorphisms in a donor population from southeast Brazil and their correlation with VEL expression.
Arnoni CP; De Paula Vendrame TA; Muniz JG; Gazito D; De Medeiros Person RD; Pereira Cortez AJ; Latini FRM; Castilho L
Blood Transfus; 2019 Jan; 17(1):60-65. PubMed ID: 29517970
[TBL] [Abstract][Full Text] [Related]
7. SMIM1 variants rs1175550 and rs143702418 independently modulate Vel blood group antigen expression.
Christophersen MK; Jöud M; Ajore R; Vege S; Ljungdahl KW; Westhoff CM; Olsson ML; Storry JR; Nilsson B
Sci Rep; 2017 Jan; 7():40451. PubMed ID: 28084402
[TBL] [Abstract][Full Text] [Related]
8. Impact of genetic variation in the SMIM1 gene on Vel expression levels.
Haer-Wigman L; Stegmann TC; Solati S; Ait Soussan A; Beckers E; van der Harst P; van Hulst-Sundermeijer M; Ligthart P; van Rhenen D; Schepers H; de Haas M; van der Schoot CE
Transfusion; 2015 Jun; 55(6 Pt 2):1457-66. PubMed ID: 25647324
[TBL] [Abstract][Full Text] [Related]
9. [Molecular screening for Vel- blood type and analysis of SMIM1 gene variants].
Liu T; Xu T; Liu Y; Zhang R; Dou W; Shi L; Wang P; Zhao F
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Dec; 37(12):1349-1351. PubMed ID: 33306819
[TBL] [Abstract][Full Text] [Related]
10. The Vel blood group system: a review.
Storry JR; Peyrard T
Immunohematology; 2017 Jun; 33(2):56-59. PubMed ID: 28657763
[TBL] [Abstract][Full Text] [Related]
11. Dimerization of small integral membrane protein 1 promotes cell surface presentation of the Vel blood group epitope.
Kelley LP; Nylander A; Arnaud L; Schmoker AM; St Clair RM; Gleason LA; Souza JM; Storry JR; Olsson ML; Ballif BA
FEBS Lett; 2020 Apr; 594(8):1261-1270. PubMed ID: 31879955
[TBL] [Abstract][Full Text] [Related]
12. SMIM1, carrier of the Vel blood group, is a tail-anchored transmembrane protein and readily forms homodimers in a cell-free system.
Nylander A; Leznicki P; Vidovic K; High S; Olsson ML
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32301496
[TBL] [Abstract][Full Text] [Related]
13. Molecular Screening for Vel- Blood Donors in Southwestern Germany.
Wieckhusen C; Rink G; Scharberg EA; Rothenberger S; Kömürcü N; Bugert P
Transfus Med Hemother; 2015 Nov; 42(6):356-60. PubMed ID: 26732700
[TBL] [Abstract][Full Text] [Related]
14. SMIM1 is a type II transmembrane phosphoprotein and displays the Vel blood group antigen at its carboxyl-terminus.
Arnaud L; Kelley LP; Helias V; Cartron JP; Ballif BA
FEBS Lett; 2015 Nov; 589(23):3624-30. PubMed ID: 26452714
[TBL] [Abstract][Full Text] [Related]
15. SMIM1 intron 2 gene variations leading to variability in Vel antigen expression among Brazilian blood donors.
Dezan MR; Costa-Neto A; Gomes CN; Ribeiro IH; Oliveira VB; Conrado MCAV; Oliveira TGM; Carvalho MLP; Aranha AF; Bosi SRA; Salles NA; Krieger JE; Pereira AC; Sabino EC; Rocha V; Mendrone-Junior A; Dinardo CL; Levi JE
Blood Cells Mol Dis; 2019 Jul; 77():23-28. PubMed ID: 30939337
[TBL] [Abstract][Full Text] [Related]
16. Development of a recombinant anti-Vel immunoglobulin M to identify Vel-negative donors.
van der Rijst MVE; Lissenberg-Thunnissen SN; Ligthart PC; Visser R; Jongerius JM; Voorn L; Veldhuisen B; Vidarsson G; van den Akker E; van der Schoot CE
Transfusion; 2019 Apr; 59(4):1359-1366. PubMed ID: 30702752
[TBL] [Abstract][Full Text] [Related]
17. High-throughput strategy for molecular identification of Vel- blood donors employing nucleic acids extracted from plasma pools used for viral nucleic acid test screening.
Dezan MR; Dinardo CL; Bosi SR; Vega S; Salles NA; Mendrone-Júnior A; Levi JE
Transfusion; 2016 Jun; 56(6):1430-4. PubMed ID: 27060345
[TBL] [Abstract][Full Text] [Related]
18. [Pedigree investigation and genetic analysis of a case with Vel heterozygous deletion mutation].
Liu T; Liu Y; Ma L; Zhao F; Zhang R; Shi L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Dec; 34(6):888-890. PubMed ID: 29188623
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a new human monoclonal antibody directed against the Vel antigen.
Danger Y; Danard S; Gringoire V; Peyrard T; Riou P; Semana G; Vérité F
Vox Sang; 2016 Feb; 110(2):172-8. PubMed ID: 26382919
[TBL] [Abstract][Full Text] [Related]
20. The Polymorphism of
Yu Y; Wang Z; Zhu L; Lin Y; Chang H; Xu H
Indian J Hematol Blood Transfus; 2019 Jan; 35(1):137-143. PubMed ID: 30828161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
